Nagasawa H T, Goon D J, Muldoon W P, Zera R T
J Med Chem. 1984 May;27(5):591-6. doi: 10.1021/jm00371a006.
A number of 2-alkyl- and 2-aryl-substituted thiazolidine-4(R)-carboxylic acids were evaluated for their protective effect against hepatotoxic deaths produced in mice by LD90 doses of acetaminophen. 2(RS)-Methyl-, 2(RS)-n-propyl-, and 2(RS)-n- pentylthiazolidine -4(R)-carboxylic acids (compounds 1b,d,e, respectively) were nearly equipotent in their protective effect based on the number of surviving animals at 48 h as well as by histological criteria. 2(RS)-Ethyl-, 2(RS)-phenyl-, and 2(RS)-(4-pyridyl)thiazolidine-4(R)-carboxylic acids (compounds 1c,f,g) were less protective. The enantiomer of 1b, viz., 2(RS)- methylthiazolidine -4(S)-carboxylic acid (2b), was totally ineffective in this regard. Thiazolidine-4(R)-carboxylic acid (1a), but not its enantiomer, 2a, was a good substrate for a solubilized preparation of rat liver mitochondrial proline oxidase [Km = 1.1 x 10(-4) M; Vmax = 5.4 mumol min-1 (mg of protein)-1]. Compound 1b was not a substrate for proline oxidase but dissociated to L-cysteine in this system. At physiological pH and temperature, the hydrogens on the methyl group of 1b underwent deuterium exchange with solvent D2O (k1 = 2.5 X 10(-5) s), suggesting that opening of the thiazolidine ring must have taken place. Indeed, 1b labeled with 14C in the 2 and methyl positions was rapidly metabolized by the rat to produce 14CO2, 80% of the dose being excreted in this form in the expired air after 24 h. It is suggested that these 2-substituted thiazolidine-4(R)-carboxylic acids are prodrugs of L-cysteine that liberate this sulfhydryl amino acid in vivo by nonenzymatic ring opening, followed by solvolysis.
对多种2-烷基和2-芳基取代的噻唑烷-4(R)-羧酸进行了评估,以研究它们对小鼠因给予对乙酰氨基酚LD90剂量而产生的肝毒性死亡的保护作用。2(RS)-甲基、2(RS)-正丙基和2(RS)-正戊基噻唑烷-4(R)-羧酸(分别为化合物1b、d、e),基于48小时存活动物数量以及组织学标准,它们的保护作用几乎相当。2(RS)-乙基、2(RS)-苯基和2(RS)-(4-吡啶基)噻唑烷-4(R)-羧酸(化合物1c、f、g)的保护作用较弱。1b的对映体,即2(RS)-甲基噻唑烷-4(S)-羧酸(2b),在这方面完全无效。噻唑烷-4(R)-羧酸(1a),而不是其对映体2a,是大鼠肝线粒体脯氨酸氧化酶溶解制剂的良好底物[Km = 1.1×10(-4)M;Vmax = 5.4 μmol min-1(mg蛋白质)-1]。化合物1b不是脯氨酸氧化酶的底物,但在该系统中会解离为L-半胱氨酸。在生理pH和温度下,1b甲基上的氢与溶剂D2O发生氘交换(k1 = 2.5×10(-5)s),这表明噻唑烷环必定已经打开。实际上,在2位和甲基位用14C标记的1b被大鼠迅速代谢产生14CO2,24小时后80%的剂量以这种形式在呼出气体中排出。有人提出,这些2-取代的噻唑烷-4(R)-羧酸是L-半胱氨酸的前药,它们通过非酶促开环,随后进行溶剂解作用,在体内释放出这种巯基氨基酸。